Total Payments
$27,932
2024 Payments
$3,924
Companies
36
Transactions
900
Medicare Patients
1,587
Medicare Billing
$391,475
Payment Breakdown by Category
Food & Beverage$24,209 (86.7%)
Other$3,096 (11.1%)
Consulting$604.00 (2.2%)
Education$23.07 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,209 | 891 | 86.7% |
| Honoraria | $3,096 | 2 | 11.1% |
| Consulting Fee | $604.00 | 3 | 2.2% |
| Education | $23.07 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $4,043 | 165 | $0 (2024) |
| Horizon Therapeutics plc | $3,861 | 24 | $0 (2023) |
| PFIZER INC. | $3,120 | 175 | $0 (2024) |
| UCB, Inc. | $2,957 | 79 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,425 | 65 | $0 (2024) |
| ABBVIE INC. | $2,355 | 85 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,029 | 58 | $0 (2024) |
| Lilly USA, LLC | $1,466 | 60 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $893.22 | 15 | $0 (2024) |
| Genentech USA, Inc. | $783.78 | 27 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,924 | 118 | ABBVIE INC. ($762.99) |
| 2023 | $3,555 | 111 | UCB, Inc. ($692.44) |
| 2022 | $5,303 | 109 | Horizon Therapeutics plc ($2,335) |
| 2021 | $1,476 | 60 | PFIZER INC. ($306.46) |
| 2020 | $2,655 | 49 | Horizon Therapeutics plc ($1,222) |
| 2019 | $4,435 | 173 | Amgen Inc. ($793.50) |
| 2018 | $3,711 | 158 | Amgen Inc. ($743.85) |
| 2017 | $2,873 | 122 | Amgen Inc. ($701.08) |
All Payment Transactions
900 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.79 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/16/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Inflammation | ||||||
| 12/14/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/17/2024 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 11/16/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $137.43 | General |
| Category: Rheumatology | ||||||
| 11/15/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $133.89 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/14/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/08/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.27 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Inflammation | ||||||
| 10/18/2024 | SOBI, INC | KINERET (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $33.39 | General |
| Category: Immunology | ||||||
| 09/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/18/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $33.68 | General |
| Category: Immunology | ||||||
| 09/12/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 431 | 1,172 | $189,357 | $97,622 |
| 2022 | 5 | 403 | 1,119 | $191,436 | $100,835 |
| 2021 | 5 | 382 | 1,303 | $211,967 | $114,477 |
| 2020 | 6 | 371 | 1,135 | $182,380 | $78,541 |
Total Patients
1,587
Total Services
4,729
Medicare Billing
$391,475
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 273 | 868 | $149,296 | $81,799 | 54.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 50 | 50 | $12,500 | $6,904 | 55.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 78 | $8,892 | $4,919 | 55.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 14 | 53 | $13,886 | $3,386 | 24.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 47 | $1,363 | $553.05 | 40.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 76 | $3,420 | $61.11 | 1.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 277 | 925 | $159,100 | $86,459 | 54.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 49 | 49 | $12,250 | $6,915 | 56.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 58 | $6,612 | $3,915 | 59.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 12 | 47 | $12,314 | $3,087 | 25.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 22 | 40 | $1,160 | $458.40 | 39.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 290 | 1,085 | $186,620 | $106,772 | 57.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 58 | $6,612 | $3,911 | 59.1% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 20 | 55 | $14,410 | $3,465 | 24.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 17 | 25 | $725.00 | $255.99 | 35.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 17 | 80 | $3,600 | $73.57 | 2.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 275 | 913 | $157,036 | $72,560 | 46.2% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 19 | 58 | $15,196 | $3,186 | 21.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 48 | $5,472 | $2,366 | 43.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 14 | 19 | $551.00 | $202.56 | 36.8% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 12 | 12 | $300.00 | $134.42 | 44.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 15 | 85 | $3,825 | $93.07 | 2.4% |
About Dr. Kristine Uramoto, M.D
Dr. Kristine Uramoto, M.D is a Rheumatology healthcare provider based in Honolulu, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295747343.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kristine Uramoto, M.D has received a total of $27,932 in payments from pharmaceutical and medical device companies, with $3,924 received in 2024. These payments were reported across 900 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($24,209).
As a Medicare-enrolled provider, Uramoto has provided services to 1,587 Medicare beneficiaries, totaling 4,729 services with total Medicare billing of $391,475. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Honolulu, HI
- Active Since 08/13/2006
- Last Updated 08/20/2009
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1295747343
Products in Payments
- KRYSTEXXA (Biological) $4,205
- Enbrel (Biological) $2,113
- BENLYSTA (Biological) $1,855
- XELJANZ (Drug) $1,721
- RINVOQ (Biological) $1,680
- Cimzia (Drug) $1,360
- COSENTYX (Biological) $1,297
- TALTZ (Drug) $1,136
- COSENTYX (Drug) $1,015
- LUPKYNIS (Drug) $893.22
- SAPHNELO (Biological) $693.56
- EVENITY (Biological) $658.33
- ACTHAR (Biological) $585.14
- Rituxan (Biological) $501.09
- LYRICA (Drug) $492.65
- Prolia (Biological) $459.07
- KEVZARA (Biological) $380.08
- Humira (Biological) $350.29
- Tymlos (Biological) $324.11
- Otezla (Drug) $307.81
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Honolulu
Dr. Scott Kawamoto, M.d, M.D
Rheumatology — Payments: $79,238
Rheumatology $79,238
Dr. Daniel Brandt, M.d, M.D
Rheumatology — Payments: $39,628
Rheumatology $39,628
Deryll Ambrocio, Md, MD
Rheumatology — Payments: $33,495
Rheumatology $33,495
Dr. Mari Shiraishi, M.d, M.D
Rheumatology — Payments: $6,717
Rheumatology $6,717
Denny Nakayama, Md, MD
Rheumatology — Payments: $4,446
Rheumatology $4,446
Heejae Jung, Pa-C, PA-C
Rheumatology — Payments: $2,836
Rheumatology $2,836